Medicines / Pharmaceuticals
Patents for pharmaceuticals and access to affordable medicines: towards an all encompassing access paradigm for Africa
... of pharmaceuticals and the existing flexibilities in the TRIPS Agreement that countries seeking access to affordable patented pharmaceutical products might ...
9
Bel plant: A source of pharmaceuticals and ethno medicines
... Bel is a holy native tree of India, which has high ethnomedicinal, therapeutic, and pharmaceutical importance. Bel contains many diverse bioactive components in leaves, flowers, fruits, wood, root, and bark which show ...
19
Patents for pharmaceuticals and access to affordable medicines: towards an all encompassing access paradigm for Africa
... to medicines is a significant component of the right to health 199 and about two billion people have been reported to lack access to essential medicines all over the ...Essential Medicines was drawn ...
325
CONSUMER PERCEPTION AND BRAND LOYALTY TOWARDS OVER THE COUNTER BRAND MEDICINES OF MAJOR PHARMACEUTICALS COMPANIES WITH SPECIAL REFERENCE TO RAJASTHAN
... As the numbers of OTC products are available in market with different therapeutic segment which are make available to consumers and most of the purchasing of OTC are made through Pharmacist or chemist retailer. The ...
12
Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias’ in access to imported medicines in Tanzania and its policy implications
... Results: Medicines produced in Tanzania were equally likely to be found in rural and in urban ...Imported medicines, especially those imported from countries other than Kenya (mainly from India) displayed ‘ ...
12
MICROBIAL CONTAMINATION OF PHARMACEUTICALS
... herbal medicines are less likely than free to bind with molecules in our body and thus slower to be absorbed, the issue of safety and vigilance on its serious adverse effects be of a ...
10
The elements of life and medicines
... Fluorides seem to regulate their activity through the mitogen-activated protein kinases MAPK signalling pathway which can result in alterations to gene expression, cell stress and cell death [424]. Fluoride metabolism in ...
57
European Medicines Agency. Annual report of the European Medicines Agency 2006
... An important part of the Agency’s cooperation with the US Food and Drug Administration and the Japanese Ministry of Health takes place under the umbrella of the International Conference on Harmonisation of Technical ...
134
VERTEX PHARMACEUTICALS INC / MA
... We believe that our integrated drug design approach has significantly enhanced our ability to discover and develop small molecule drug candidates directed at biologically complex targets associated with serious ...
161
The sociology of pharmaceuticals: progress and prospects
... ‘tailor-made’ medicines, construed as the perfect antidote to the ‘one-size-fits-all’ remedies currently on the market where side-effects or adverse drug reactions (ADRs) are ...
25
Microbial factories for recombinant pharmaceuticals
... recombinant pharmaceuticals so far approved for human use by the Food and Drug Administration (FDA) and/or by the European Medicines Agency (EMEA) are microbial cells, either bacteria or ...those ...
8
European Medicines Agency. Annual report of the European Medicines Agency 2008
... VTE). Both medicines can be administered by mouth and do not require laboratory monitoring, representing an alternative to conventional therapy by injection. One is a factor Xa inhibitor (it blocks factor Xa, an ...
158
European Medicines Agency. Annual report of the European Medicines Agency 2007
... to medicines for developing countries; consolidating its information-exchange programme with the US Food and Drug Administration in relation to human and veterinary medicines; and signing confidentiality ...
138
A Guide to the Science Underpinning Pharmaceutical Practice May 2014 NEW MEDICINES, BETTER MEDICINES, BETTER USE OF MEDICINES
... new medicines and research on their subsequent use in the health service are core activities of the pharmaceutical scientist, while pharmacists in clinical roles directly interact with other healthcare ...
120
"Generic Entry and the Pricing of Pharmaceuticals"
... gJJG 9AGL9aG bLTcG o bLGBcLrbgTou ;o cowborrnq 2rrpJGGg go LGflCG bLTcG O aGLJGLTG BnpBgTgngG (32 - 3Oe JoL 11i691J2 gpg aGIJGLTG bLOg1TGGL (O - 2O) 9101-Ta Mp gp ]-aLJTTc9IJgTx. LPG np2[r] ...
24
Qualification of Excipients for Use in Pharmaceuticals
... The evaluation of supplier test methodology can include discussions with the supplier to gain an understanding of their release testing and validation activities The supplier should di[r] ...
66
PHARMACEUTICALS IN THE ENVIRONMENT
... for pharmaceuticals, ranging from less than 20% to greater than ...of pharmaceuticals varies within and between studies and is dependent on operational configuration of the wastewater treatment ...
8
European Medicines Agency. Annual report of the European Medicines Agency 2005
... veterinary medicines, the Agency is responsible for all medicinal products derived from biotechnology or intended primarily for use as performance enhancers to promote growth of or to increase yield from treated ...
112
VERTEX PHARMACEUTICALS INC / MA
... On September 6, 2012, a purported securities class action lawsuit was commenced in the United States District Court for the District of Massachusetts under the caption City of Bristol Pension Fund v. Vertex ...
161
The Demand for PBS Medicines
... of medicines is how to construct the aggregate quantity ...of medicines these are not ...of medicines that will have significantly fewer observations than might be ...
37